These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 16900654)
1. [Application of imiquimod and resiquimod in dermatology]. Xu KJ; Liu YH Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Jun; 28(3):445-7. PubMed ID: 16900654 [TBL] [Abstract][Full Text] [Related]
2. Imiquimod; an international update on therapeutic uses in dermatology. Tyring S; Conant M; Marini M; Van Der Meijden W; Washenik K Int J Dermatol; 2002 Nov; 41(11):810-6. PubMed ID: 12453012 [TBL] [Abstract][Full Text] [Related]
4. [Imiquimod--a substance with a broad working spectrum]. Oster-Schmidt C J Dtsch Dermatol Ges; 2004 Oct; 2(10):821-2. PubMed ID: 16281584 [No Abstract] [Full Text] [Related]
5. The role of topical immune response modifiers in skin cancer. Woodmansee C; Pillow J; Skinner RB Drugs; 2006; 66(13):1657-64. PubMed ID: 16978032 [TBL] [Abstract][Full Text] [Related]
6. Imiquimod in dermatology: an overview. Hanna E; Abadi R; Abbas O Int J Dermatol; 2016 Aug; 55(8):831-44. PubMed ID: 27387373 [TBL] [Abstract][Full Text] [Related]
9. The use of topical 5% imiquimod during pregnancy: a case series. Einarson A; Costei A; Kalra S; Rouleau M; Koren G Reprod Toxicol; 2006 Jan; 21(1):1-2. PubMed ID: 16039826 [No Abstract] [Full Text] [Related]
10. Successful treatment of perianal warts in a child with 5% imiquimod cream. Gruber PC; Wilkinson J J Dermatolog Treat; 2001 Dec; 12(4):215-7. PubMed ID: 12241631 [TBL] [Abstract][Full Text] [Related]
19. [Imiquimod and resiquimod. The onset of a new pharmaco-therapeutic class?]. Chosidow O; Cribier B; Aractingi S Ann Dermatol Venereol; 2003; 130(8-9 Pt 1):713-7. PubMed ID: 14576599 [No Abstract] [Full Text] [Related]